Resistance to most of the antitubercular drugs has been on rising trends due to the misuse of existing drugs. This has encouraged us to explore a novel scaffold that has the potential for quick antimicrobial action with minimum side effects. Nitrofurans have attracted us due to their extensive biological activities, such as antibacterial and antifungal activities.
The antitubercular activities of 126 nitrofuran derivatives have been investigated by using indicator parameters and topological and structural fragment descriptors.
The different quantitative structure activity relationship (QSAR) models have been created and validated by using two different methodologies: combinatorial protocol in multiple linear regression (CP-MLR) and partial least-squares (PLS) analysis.
The 16 descriptors identified in CP-MLR are from six different classes: Constitutional, Functional, Atom Centered Fragments, Topological, Galvez, and 2D autocorrelation. Indicator parameters and Dragon descriptors suggested that the presence of a furan ring substituted by nitro group is essential for antitubercular activity. Further descriptors from constitutional, and functional classes suggest that the number of double bonds, number of sulphur atoms and number of fragments like thiazole, morpholine and thiophene should be minimum, along with the positive influence of Kier-Hall electrotopological states (Ss) for improved activity. The ACF class descriptors, GALVEZ class descriptors, and 2D-AUTO descriptor GATS4p have also shown positive influence on the antitubercular activity. The TOPO class descriptor T(O…S) suggests that the minimum gap between sulphur and oxygen is favorable for activity.
The models acknowledged in the study have explained the variance between 72 to 76% in the training set and in the prediction of the test set compounds. Also, compounds 122, 123 and 82 were found to possess good binding affinity towards nitroreductase.
Citation: Smriti Sharma, Brij K. Sharma, Surabhi Jain, Anubhav Rana. 2D-QSAR and molecular docking study on nitrofuran analogues as antitubercular agents[J]. AIMS Molecular Science, 2024, 11(1): 1-20. doi: 10.3934/molsci.2024001
Resistance to most of the antitubercular drugs has been on rising trends due to the misuse of existing drugs. This has encouraged us to explore a novel scaffold that has the potential for quick antimicrobial action with minimum side effects. Nitrofurans have attracted us due to their extensive biological activities, such as antibacterial and antifungal activities.
The antitubercular activities of 126 nitrofuran derivatives have been investigated by using indicator parameters and topological and structural fragment descriptors.
The different quantitative structure activity relationship (QSAR) models have been created and validated by using two different methodologies: combinatorial protocol in multiple linear regression (CP-MLR) and partial least-squares (PLS) analysis.
The 16 descriptors identified in CP-MLR are from six different classes: Constitutional, Functional, Atom Centered Fragments, Topological, Galvez, and 2D autocorrelation. Indicator parameters and Dragon descriptors suggested that the presence of a furan ring substituted by nitro group is essential for antitubercular activity. Further descriptors from constitutional, and functional classes suggest that the number of double bonds, number of sulphur atoms and number of fragments like thiazole, morpholine and thiophene should be minimum, along with the positive influence of Kier-Hall electrotopological states (Ss) for improved activity. The ACF class descriptors, GALVEZ class descriptors, and 2D-AUTO descriptor GATS4p have also shown positive influence on the antitubercular activity. The TOPO class descriptor T(O…S) suggests that the minimum gap between sulphur and oxygen is favorable for activity.
The models acknowledged in the study have explained the variance between 72 to 76% in the training set and in the prediction of the test set compounds. Also, compounds 122, 123 and 82 were found to possess good binding affinity towards nitroreductase.
[1] | Sensi P, Grassi GG (2003) Antimycobacterial agents. Burger's medicinal chemistry and drug discovery.John Wiley & Sons, Inc.. https://doi.org/10.1002/0471266949.bmc089 |
[2] | Bannalikar AS, Verma R (2006) Detection of Mycobacterium avium & M. tuberculosis from human sputum cultures by PCR-RFLP analysis of hsp65 gene & pncA PCR. Indian J Med Res 123: 165-172. |
[3] | Frieden TR, Sterling TR, Munsiff SS, et al. (2003) Tuberculosis. Lancet 362: 887-899. https://doi.org/10.1016/S0140-6736(03)14333-4 |
[4] | Schmidt CW (2008) Linking TB and the environment: An overlooked mitigation strategy. Environ Health Persp 116: A478-A485. https://doi.org/10.1289/ehp.116-a478 |
[5] | Khasnobis S, Escuyer VE, Chatterjee D (2002) Emerging therapeutic targets in tuberculosis: Post-genomic era. Expert Opin Ther Targets 6: 21-40. https://doi.org/10.1517/14728222.6.1.21 |
[6] | Takayama K, Wang C, Besra GS (2005) Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis. Clin microbiol Rev 18: 81-101. https://doi.org/10.1128/cmr.18.1.81-101.2005 |
[7] | Molle V, Brown AK, Besra GS, et al. (2006) The condensing activities of the Mycobacterium tuberculosis type II fatty acid synthase are differentially regulated by phosphorylation. J Biol Chem 281: 30094-30103. https://doi.org/10.1074/jbc.M601691200 |
[8] | Kaufmann SHE (2001) How can immunology contribute to the control of tuberculosis?. Nat Rev Immunol 1: 20-30. https://doi.org/10.1038/35095558 |
[9] | Cardona P, Cardona PJ (2019) Regulatory T cells in Mycobacterium tuberculosis infection. Front Immunol 10: 2139. https://doi.org/10.3389/fimmu.2019.02139 |
[10] | Schluger NW, Rom WN (1998) The host immune response to tuberculosis. Am J Resp Crit Care 157: 679-691. https://doi.org/10.1164/ajrccm.157.3.9708002 |
[11] | WHOWHO factsheet 2022 (2022). Available at: https://cdn.who.int/media/docs/default-source/hq-tuberculosis/global-tuberculosis-report-2022/global-tb-report-2022-factsheet |
[12] | Velayati AA, Masjedi MR, Farnia P, et al. (2009) Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in Iran. Chest 136: 420-425. https://doi.org/10.1378/chest.08-2427 |
[13] | Sharma S, Saquib M, Shaw AK (2013) Tuberculosis chemotherapy: An overview in perspective of recent developments. Chem Biol Interface 3: 205-229. |
[14] | WHOWHO news: WHO announces updated definitions of extensively drug-resistant tuberculosis (2021). Available at: https://www.who.int/news/item/27-01-2021-who-announces-updated-definitions-of-extensively-drug-resistant-tuberculosis |
[15] | Brogden RN, Heel RC, Speight TM, et al. (1978) Metronidazole in anaerobic infections: a review of its activity, pharmacokinetics and therapeutic use. Drugs 16: 387-417. https://doi.org/10.2165/00003495-197816050-00002 |
[16] | Brumfitt W, Hamilton-Miller JM (1998) Efficacy and safety profile of long-term nitrofurantoin in urinary infections: 18 years' experience. J Antimicrob Chemoth 42: 363-371. https://doi.org/10.1093/jac/42.3.363 |
[17] | Hurdle JG, Lee RB, Budha NR, et al. (2008) A microbiological assessment of novel nitrofuranylamides as antituberculosis agents. J Antimicrob Chemother 62: 1037-1045. https://doi.org/10.1093/jac/dkn307 |
[18] | Tangallapy RP, Yendapally R, Lee RE, et al. (2004) Synthesis and evaluation of nitrofuranylamides as novel antituberculosis. J Med Chem 47: 5276-5283. https://doi.org/10.1021/jm049972y |
[19] | Sharma S, Sharma BK, Prabhakar YS (2009) Juglone derivatives as antitubercular agents: A rationale for the activity profile. Eur J Med Chem 44: 2847-2853. https://doi.org/10.1016/j.ejmech.2008.12.015 |
[20] | Gupta MK, Sagar R, Shaw AK, et al. (2005) CP-MLR directed QSAR studies on the antimycobacterial activity of functionalized alkenols–topological descriptors in modeling the activity. Bioorgan Med Chem 13: 343-351. https://doi.org/10.1016/j.bmc.2004.10.025 |
[21] | Sun G, Bai P, Fan T, et al. (2023) QSAR and chemical read-across analysis of 370 potential MGMT inactivators to identify the structural features influencing inactivation potency. pharmaceutics 15: 2170. https://doi.org/10.3390/pharmaceutics15082170 |
[22] | Chen S, Sun G, Fan T, et al. (2023) Ecotoxicological QSAR study of fused/non-fused polycyclic aromatic hydrocarbons (FNFPAHs): Assessment and priority ranking of the acute toxicity to Pimephales promelas by QSAR and consensus modeling methods. Sci Total Environ 876: 162736. https://doi.org/10.1016/j.scitotenv.2023.168736 |
[23] | Li F, Sun G, Fan T, et al. (2023) Ecotoxicological QSAR modelling of the acute toxicity of fused and non-fused polycyclic aromatic hydrocarbons (FNFPAHs) against two aquatic organisms: Consensus modelling and comparison with ECOSAR. Aquat Toxicol 255: 106393. https://doi.org/10.1016/j.aquatox.2022.106393 |
[24] | Hevener KE, Ball DM, Buolamwini JK, et al. (2008) Quantitative structure–activity relationship studies on nitrofuranyl anti-tubercular agents. Bioorg Med Chem 16: 8042-8053. https://doi.org/10.1016/j.bmc.2008.07.070 |
[25] | Tawari NR, Degani MS (2010) Pharmacophore mapping and electronic feature analysis for a series of nitroaromatic compounds with antitubercular activity. J Comput Chem 31: 739-751. https://doi.org/10.1002/jcc.21371 |
[26] | Talete srlDragon Software (2013). Available from: http://www.talete.mi.it/products/dragon_description.htm |
[27] | Tangallapy RP, Yendapally R, Lee RE, et al. (2005) Synthesis and evaluation of cyclic secondary amine substituted phenyl and benzyl nitrofuranyl amides as novel sntituberculosis sgents. J Med Chem 48: 8261-8269. https://doi.org/10.1021/jm050765n |
[28] | Tangallapally RP, Sun D, Rakesha, et al. (2007) Discovery of novel isoxazolines as anti-tuberculosis agents. Bioorg Med Chem Lett 17: 6638-6642. https://doi.org/10.1016/j.bmcl.2007.09.048 |
[29] | Tangallapally RP, Yendapally R, Daniels AJ, et al. (2007) Nitrofurans as novel anti-tuberculosis agents: Identification, development and evaluation. Curr Top Med Chem 7: 509-526. https://doi.org/10.2174/156802607780059772 |
[30] | Sun D, Scherman MS, Jones V, et al. (2009) Discovery, synthesis, and biological evaluation of piperidinol analogs with anti-tuberculosis activity. Bioorgan Med Chem 17: 3588-3594. https://doi.org/10.1016/j.bmc.2009.04.005 |
[31] | Mills N (2006) ChemDraw Ultra 10.0. Cambridge Soft, 100 Cambridge Park Drive, Cambridge, MA02140. J Am Chem Soc 128: 13649-13650. https://doi.org/10.1021/ja0697875 |
[32] | Prabhakar YS (2003) A combinatorial approach to the variable selection in multiple linear regression: Analysis of Selwood et al. data set–A case study. QSAR Comb Sci 22: 583-595. https://doi.org/10.1002/qsar.200330814 |